CClinicalTrials.gg
CompletedNCT05537532IHS 2021Updated Sep 13, 2022

Intern Health Study 2021

An interventional study of Intern Health Study competition-related mobile notification and Intern Health Study mobile app in Telemedicine, sponsored by University of Michigan. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2022-09-13.

Sponsored by University of Michigan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Apr 2021, registered Sep 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
1,486
Allocation
Randomized
Sex
All
01

Study summary

The aim of this study is to evaluate the efficacy of gamified competition (delivered through a smartphone) for improving the physical activity and sleep of medical interns.

Read the detailed description

Due to their high-stress workloads, medical interns tend to have lower sleep and decreased physical activity. The goal of this study is to evaluate the efficacy of gamified competition (delivered through a smartphone) for improving the physical activity and sleep of medical interns. During the study, they are teamed up by programs and institutions and compete with other teams, which aim to motivate them to have more physical activity and sleep duration during their internship year.

The primary aim of this study is to investigate whether introducing competition mechanisms into mobile health (mHealth) interventions can improve a medical intern's activity-related behavioral outcomes: daily step counts and sleep duration. The first secondary aim is to assess the time-varying competition effect on their behavioral outcomes. The first exploratory aim is to assess the competition effect on study engagement and the second exploratory aim is to evaluate the competition effect on mental outcome, mood score.

02

Conditions studied

  • Telemedicine
03

In context

Lead sponsor

University of Michigan is the lead sponsor of 1,475 studies on the registry; 196 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Medical intern during the 2021-2022 internship year
  • Enrolled in study by the start of internship (7/1/22)

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,486 participants (actual)

Study arms

  • Experimental
    Competition group

    Programs with at least five interns were grouped into program-based teams. Interns within the same residency institution in programs that did not meet this criterion were grouped into institution-based teams, with a minimum of five participants per team. For each week, an eligible team is randomized to either a steps competition or non-competition group with 50/50 chance. For those randomized to competition arm, teams were assigned an opponent team by total randomization, by which the opponent team was assigned regardless of institution and specialty.

    Behavioral: Intern Health Study competition-related mobile notification · Behavioral: Intern Health Study mobile app · Behavioral: Intern Health Study mobile app competition scoreboard and history

  • Experimental
    Non-competition group

    For each week, an eligible team is randomized to either competition or non-competition group with 50/50 chance.

    Behavioral: Intern Health Study mobile app

Interventions

  • BehavioralIntern Health Study competition-related mobile notification

    Participants will receive three types of push notifications: 1. Alert of competition type (steps or sleep) and opponent (Sunday 9pm), 2. Competition score status update (Wednesday 9pm, Saturday 11am), and 3. Competition final results (Monday 12pm).

  • BehavioralIntern Health Study mobile app

    The Intern Health Study mobile app is able to conduct a daily mood survey. It also aggregates and visualizes historical data on intern mood, activity, and sleep.

  • BehavioralIntern Health Study mobile app competition scoreboard and history

    Participant can view their current competition scoreboard and competition history at any time via the study app.

06

What researchers measure

Primary outcomes

  1. Average daily step count

    Participants' daily step counts are recorded through a Fitbit or an apple watch. High step counts are considered a positive outcome as it indicates more physical activity. For teams randomized into competition arm and randomized to compete on step count, their average daily step count is compared with the average step count of the opponent team.

    Time frame: Daily, throughout intern year (1 year)

Secondary outcomes

  1. Average daily mood score

    Through the study mobile app, participants enter a mood score (scale 1-10) every day of the study. 1 corresponds to lowest mood and 10 corresponds to highest mood.

    Time frame: Daily, throughout intern year (1 year)

07

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified genomic and survey information (baseline survey, plus quarterly survey which contains the PHQ-9) will be shared with the National Institute for Mental Health (NIMH).

Supporting information: Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 13, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05537532
Lead sponsor
University of Michigan
Responsible party
Srijan Sen (Research Professor, University of Michigan) — Principal investigator
First posted
Sep 13, 2022
Start date
Apr 1, 2021
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update
Sep 13, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion